ULURU INC. COMPLETES ALTRAZEAL® LICENSE AGREEMENT FOR EUROPE

01/17/2012

Addison, Texas, January 17, 2012; ULURU Inc. (NYSE AMEX: ULU), announced today that the License Agreement with Melmed Holdings AG for the marketing of Altrazeal® in Europe, Australia, New Zealand, the Middle East and Northern Africa has been finalized. Read More